FDA Inspection 721383 — Receptopharm Inc

Receptopharm Inc — FEI 3005400337

The FDA completed an inspection of Receptopharm Inc on April 20, 2011 in Plantation, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 20, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Plantation, FL (United States)

Citations

IDCFRDescription
104921 CFR 211.22(a)Approve or reject components, products
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
155021 CFR 211.125(f)Procedures Written and Followed
187421 CFR 211.180(b)Record maintenance 3 years (exempt OTC drugs)
434421 CFR 211.160(b)(1)Sampling and testing procedures described
900121 CFR 211.22(a)Lack of quality control unit